Plant molecular farming for the production of valuable proteins – Critical evaluation of achievements and future challenges

Alam, 2018, Technoeconomic modeling of plant-based griffithsin manufacturing, Front. Bioeng. Biotechnol., 24, 102, 10.3389/fbioe.2018.00102 Arévalo-Villalobos, 2020, Using carrot cells as biofactories and oral delivery vehicles of LTB-Syn: a low-cost vaccine candidate against synucleinopathies, J. Biotechnol., 10, 75, 10.1016/j.jbiotec.2019.12.007 Arfi, 2016, Polyclonal antibodies for specific detection of tobacco host cell proteins can be efficiently generated following RuBisCO depletion and the removal of endotoxins, Biotechnol. J., 11, 507, 10.1002/biot.201500271 Buntru, 2014, Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system, BMC Biotechnol., 14 Buntru, 2015, A versatile coupled cell-free transcription–translation system based on tobacco BY-2 cell lysates, Biotechnol. Bioeng., 112, 867, 10.1002/bit.25502 Buyel, 2017, Very-large-scale production of antibodies in plants: the biologization of Manufacturing, Biotechnol. Adv., 35, 458, 10.1016/j.biotechadv.2017.03.011 Capell, 2020, Potential applications of plant biotechnology against SARSCoV-2, Trends Plant Sci., 25, 635, 10.1016/j.tplants.2020.04.009 Clarke, 2017, Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination, Plant Biotechnol. J., 15, 1611, 10.1111/pbi.12743 De Cosa, 2001, Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals, Nat. Biotechnol., 19, 71, 10.1038/83559 Fischer, 2012, GMP issues for recombinant plant-derived pharmaceutical proteins, Biotechnol. Adv., 30, 434, 10.1016/j.biotechadv.2011.08.007 Fischer, 2013, Commercial aspects of pharmaceutical production in plants, Curr. Pharm. Des., 19, 5471, 10.2174/1381612811319310002 Fox, 2006, Turning plants into protein factories, Nat. Biotechnol., 24, 1191, 10.1038/nbt1006-1191 Häkkinen, 2014, Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody, Biotechnol. Bioeng., 11, 336, 10.1002/bit.25113 Hansen, 2017, Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: lessons learned and future directions, Biotechnol. Adv., 35, 64, 10.1016/j.biotechadv.2016.11.008 Hauptmann, 2015, In planta production of ELPylated spidron-based proteins results results in non-cytotoxic biopolymers, BMC Biotechnol., 15 Havenith, 2014, Image-based analysis of cell-specific productivity for plant cell suspension cultures, Plant Tissue Cell Organ Cult., 117, 393, 10.1007/s11240-014-0448-x Havenith, 2017, Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants, Biotechnol. J., 12, 10.1002/biot.201600441 Hiatt, 1989, Production of antibodies in transgenic plants, Nature, 2, 76, 10.1038/342076a0 Hollak, 2010, Force Majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease, Blood Cells Mol. Dis., 44, 41, 10.1016/j.bcmd.2009.09.006 Hood, 1997, Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification, Mol. Breed., 3, 291, 10.1023/A:1009676322162 Hood, 1999, Molecular farming of industrial proteins from transgenic maize, Adv. Exp. Med. Biol., 464, 127, 10.1007/978-1-4615-4729-7_11 Huck, 2017, Combined 15N-labeling and tandemMOAC quantifies phosphorylation of MAP kinase substrates downstream of MKK7 in Arabidopsis, Front. Plant Sci., 8, 2050, 10.3389/fpls.2017.02050 Kurup, 2020, Edible vaccines: promises and challenges, Mol. Biotechnol., 62, 79, 10.1007/s12033-019-00222-1 Lai, 2018, A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity, Vaccine, 27, 1846, 10.1016/j.vaccine.2018.02.073 Ma, 2015, Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants, Plant Biotechnol. J., 13, 1106, 10.1111/pbi.12416 Madeira, 2016, High-yield production of a human monoclonal IgG by rhizosecretion in hydroponic tobacco cultures, Plant Biotechnol. J., 14, 615, 10.1111/pbi.12407 Magnusdottir, 2013, Barley grains for the production of endotoxin-free growth factors, Trends Biotechnol., 31, 572, 10.1016/j.tibtech.2013.06.002 Mandal, 2016, Tackling unwanted proteolysis in plant production hosts used for molecular farming, Front. Plant Sci., 7, 267, 10.3389/fpls.2016.00267 Marillonnet, 2005, Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants, Nat. Biotechnol., 23, 718, 10.1038/nbt1094 Nölke, 2003, Production of therapeutic antibodies in plants, Expert Opin. Biol. Ther., 3, 1153, 10.1517/14712598.3.7.1153 Park, 2016, Potential of plants to produce recombinant protein products, Plant Biol., 59, 559, 10.1007/s12374-016-0482-9 Pastores, 2014, Blood Cells Mol. Dis., 53, 253, 10.1016/j.bcmd.2014.05.004 Pastores, 2016, Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase, Am. J. Hematol., 91, 661, 10.1002/ajh.24399 Pettit, 2016, CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody, MAbs, 8, 347, 10.1080/19420862.2015.1127492 Phan, 2020, Immunization with plant-derived multimeric H5 hemagglutinins protect chicken against highly pathogenic avian influenza virus H5N1, Vaccines, 9, E593, 10.3390/vaccines8040593 Ponndorf, 2020, Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice, Plant Biotechnol. J. Pujar, 2017, Antibody purification: drivers of change Qiu, 2016, Two-mAb cocktail protects macaques against the makona variant of Ebola virus, Sci. Transl. Med., 9, 10.1126/scitranslmed.aad9875 Raven, 2015, Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200 L orbitally shaken disposable bioreactor, Biotechnol. Bioeng., 112, 308, 10.1002/bit.25352 Rosales-Mendoza, 2020, What does plant-based vaccine technology offer to the fight against COVID-19?, Vaccines, 14, 183, 10.3390/vaccines8020183 Sack, 2015, From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants, Plant Biotechnol. J., 13, 1094, 10.1111/pbi.12438 Safarnejad, 2011, Antibody-mediated resistance against plant pathogens, Biotechnol. Adv., 29, 961, 10.1016/j.biotechadv.2011.08.011 Santoni, 2019, Plant-made Bet v 1 for molecular diagnosis, Front. Plant Sci., 10, 1273, 10.3389/fpls.2019.01273 Schillberg, 1999, Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum, Transgenic Res., 8, 255, 10.1023/A:1008937011213 Schillberg, 2013, Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures, Curr. Pharm. Des., 19, 5531, 10.2174/1381612811319310008 Schillberg, 2019, Critical analysis of the commercial potential of plants for the production of recombinant proteins, Front. Plant Sci., 10, 720, 10.3389/fpls.2019.00720 Schouest, 2012, Improved texture and appearance of human facial skin after daily topical application of barley produced, synthetic, human-like epidermal growth factor (EGF) serum, J. Drugs Dermatol., 11, 613 Schwestka, 2020, Plant-derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells, Biotechnol. Bioeng., 117, 1037, 10.1002/bit.27273 Shaaltiel, 2007, Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system, Plant Biotechnol. J., 5, 579, 10.1111/j.1467-7652.2007.00263.x Sijmons, 1990, Production of correctly processed human serum albumin in transgenic plants, Biotechnology, 8, 217 Spiegel, 2018, Current status and perspectives of the molecular farming landscape Stieger, 1987 Stieger, 1991, Self assembly of immunoglobulins in the cytoplasm of the alga Acetabularia mediterranea, Plant Sci., 73, 181, 10.1016/0168-9452(91)90027-6 Tacket, 2000, Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes, J. Infect. Dis., 182, 302, 10.1086/315653 Tavladoraki, 1993, Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack, Nature, 366, 469, 10.1038/366469a0 Topp, 2016, The case for plant-made veterinary immunotherapeutics, Biotechnol. Adv., 34, 597, 10.1016/j.biotechadv.2016.02.007 Twyman, 2003, Molecular farming in plants: host systems and expression technology, Trends Biotechnol., 21, 570, 10.1016/j.tibtech.2003.10.002 Twyman, 2005, Transgenic plants in the biopharmaceutical market, Expert Opin. Emerg. Drugs, 10, 185, 10.1517/14728214.10.1.185 Ullisch, 2012, Comprehensive characterization of two different Nicotiana tabacum cell lines leads to doubled GFP and HA protein production by media optimization, J. Biosci. Bioeng., 113, 242, 10.1016/j.jbiosc.2011.09.022 Van der Veen, 2020, Developments in the treatment of Fabry disease, J. Inherit. Metab. Dis., 43, 908, 10.1002/jimd.12228 Vasilev, 2013, Optimization of BY-2 cell suspension culture medium for the production of a human antibody using a combination of fractional factorial designs and the response surface method, Plant Biotechnol. J., 11, 867, 10.1111/pbi.12079 Virdi, 2013, Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection, Proc. Natl. Acad. Sci. U S A, 16, 11809, 10.1073/pnas.1301975110 Voss, 1995, Reduced virus infectivity in N. Tabacum secreting a TMV-specific full-size antibody, Mol. Breed., 1, 39, 10.1007/BF01682088 Ward, 2020, Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials, Lancet, 7, 1491, 10.1016/S0140-6736(20)32014-6 Yamamoto, 2018, Improvement of the transient expression system for production of recombinant proteins in plants, Sci. Rep., 8, 4755, 10.1038/s41598-018-23024-y Yao, 2015, Plants as factories for human pharmaceuticals: applications and challenges, Int. J. Mol. Sci., 16, 28549, 10.3390/ijms161226122 Zimran, 2018, Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase, Blood Cells Mol. Dis., 68, 163, 10.1016/j.bcmd.2016.10.005 Zimran, 2018, Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease, Orphanet J. Rare Dis., 13, 36, 10.1186/s13023-018-0776-8